Back

Effect of secondary prevention: low density lipoprotein cholesterol and lipid-lowering drug use after first-ever myocardial infarction, by sex and age

6 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1 Epidemiology, lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Laila Hopstock

UiT The Arctic University of Norway, Tromso (Norway)

15 More presentations in this session

Presentation thumbnail
Epidemiology/ Public health_Part 1 - Poster discussant:.
Presentation thumbnail
Changes in body weight and composition are associated with changes in left ventricular and atrial geometry in the general population
Presentation thumbnail
Differences in measured and self-reported anthropometric data: the Italian Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 2008-2012
Doctor L. Palmieri (Rome, IT)
Abstract
Presentation thumbnail
Clinical implications of low-to-intermediate trials for primary prevention of atherosclerotic CVD and risk stratification with N-terminal pro-B-type natriuretic peptide in the Rotterdam Study
Doctor J. Pavlovic (Rotterdam, NL)
Abstract
Presentation thumbnail
Leisure time physical activity initiated by employer and its health effects. A 15-month follow-up study
Doctor M. Skogstad (Oslo, NO)
Abstract

Access the full session

Session thumbnail
Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1

The Event

Event poster

EuroPrevent 2017

6 April - 8 April 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources